Penalties and Enforcement Consequences of Non-Compliance (Malaysia)

Selling non-compliant products in Malaysia has consequences beyond being "asked to correct." Depending on the product category, you may face seizure by the authority, delisting and recall of the product, administrative sanctions, and even criminal prosecution—most laws provide for both a fine and imprisonment, and both the legal entity (the company) and the responsible officers may be pursued. This article organises the penalties and enforcement processes under the main laws for food, medicines and cosmetics, and consumer protection, so that before launch you know clearly where the red lines are and how heavy the price is.

First, a concept to establish: which law a penalty "hangs on" depends on how the product is categorised. Food goes under the Food Act 1983, medicines / traditional medicine / supplements / cosmetics under the Sale of Drugs Act 1952 and the CDCR 1984 beneath it, while false labelling, misleading advertising and unsafe goods may additionally breach the Consumer Protection Act 1999. The same act may breach several laws at once.

Quick reference: penalties under the main laws

Advertising violations (such as unapproved therapeutic advertising) are additionally governed by the Medicines (Advertisement and Sale) Act 1956, which provides for penalties; the amounts are subject to the latest official text of that Act, and this article does not state figures directly.

Enforcement and consequences go beyond fines

A fine is often only the loss on paper. In practice, the more painful part is the collateral consequences:

• Seizure and delisting: authorised officers may enter to inspect, sample and seize non-compliant goods, and channels delist immediately.
• Product recall: for traditional medicines / supplements adulterated with Western medicine, NPRA will issue a public alert and order a recall and cancel the registration, severely damaging brand reputation.
• Channel liability: e-commerce platforms (such as Shopee, Lazada), on receiving notice from the authority, delist the product and freeze the storefront, affecting your other normal products too.
• Officer liability: when a body corporate commits an offence, the directors, managers and other actual persons in charge may be pursued as well.

High-risk red lines (most frequently checked)

• Supplements / traditional medicines adulterated with Western-medicine ingredients (such as slimming products adulterated with sibutramine), a key target of NPRA inspection and recall.
• Selling unregistered medicines or un-notified cosmetics—CDCR 1984 expressly provides for an individual fine of up to RM25,000 or imprisonment of 3 years.
• False or misleading food labelling (exaggerated efficacy, fake origin), breaching Food Act §15/§16.
• Running therapeutic advertising without approval.

Frequently asked questions (FAQ)

Q: What happens if I sell unregistered supplements? Under CDCR 1984 (based on the Sale of Drugs Act 1952), selling / importing an unregistered product can result in an individual fine of up to RM25,000 or imprisonment of up to 3 years, or both, plus possible seizure and recall.

Q: How heavy are the penalties for incorrect food labelling? Under the Food Act 1983, labelling that does not conform to standards (§15) or false / misleading labelling (§16) can lead to imprisonment of up to 3 years or a fine, or both.

Q: If a company breaks the rules, is the company or the individual penalised? Both are possible. Most laws have dedicated (usually higher) penalties for bodies corporate, while the directors and managers actually in charge may also be pursued for criminal liability at the same time.

Q: Besides fines, what other consequences are there? Common ones include product seizure, ordered delisting and recall, cancellation of registration, public alerts, and e-commerce platforms delisting and freezing the storefront; the loss of reputation and revenue often far exceeds the fine itself.

Q: Can the same act breach several laws? Yes. For example, a falsely labelled supplement may simultaneously breach food/medicine-related laws and the Consumer Protection Act 1999, and the penalties may stack.

Self-check checklist

• [ ] Confirmed which law the product falls under (food / medicine and cosmetics / general goods)
• [ ] Product duly registered / notified, not sold without approval
• [ ] Labelling free of exaggerated efficacy, fake origin and other false / misleading content
• [ ] Advertising free of unapproved therapeutic claims
• [ ] Documents prepared to handle spot checks, and a recall contingency process planned

Summary: Malaysia's product laws mostly run "fine + imprisonment" in parallel, and the collateral losses of seizure, recall and platform delisting often far exceed the fine. Before launch, the most cost-effective move is to clear the red lines against your category's laws. To avoid the most common labelling pitfalls, further read A complete rundown of common reasons for label rejection and The complete compliance roadmap for entering the Malaysian market.

Run a free label check now

This article is compiled from official sources and is for reference only; actual compliance is subject to the latest official texts and review by the competent authorities.